On March 15, Jesús Izco presented NANBIOSIS at the conference organized by CIBERSAM on Therapeutic Innovation.
The event, that took place in the Hospital del Mar of Barcelona, with an audience of about 80 people, was attended by Jesús Izco, coordinator of NANBIOSIS as a guest to talk about Innovation Platforms. Jesús Izco explained the opportunities offered by the ICTS NANBIOSIS as a Platform for Research and Biomedical Innovation, giving examples of private-public collaboration in competitive calls (INNPACTOP, Challenges and H2020) in which NANBIOSIS has participated and explained the design of the new Nanomedicine Cascade Characterization Service, in which NANBIOSIS is working on.
CIBERSAM is the CIBER Scientific Area dedicated to the study of mental disorders such as depression, schizophrenia, bipolar disorder, anxiety disorders and mental disorders of the child and adolescent or therapeutic innovation. Its mission is to provide answers and solutions to better understand the etiophysiopathology of mental disorders, improving the promotion of mental health, prevention and current treatments and thus improve the quality of life of citizens. CIBERSAM’s Therapeutic Innovation program has a long tradition in the identification and development of new therapeutic strategies, both pharmacological and non-pharmacological.